Age-specific health-related quality of life in disease-free long-term prostate cancer survivors versus male population controls—results from a population-based study

2019 ◽  
Vol 28 (6) ◽  
pp. 2875-2885 ◽  
Author(s):  
Salome Adam ◽  
Daniela Doege ◽  
Lena Koch-Gallenkamp ◽  
Melissa S. Y. Thong ◽  
Heike Bertram ◽  
...  
2019 ◽  
Vol 58 (5) ◽  
pp. 801-810 ◽  
Author(s):  
Melissa S. Y. Thong ◽  
Lena Koch-Gallenkamp ◽  
Lina Jansen ◽  
Heike Bertram ◽  
Andrea Eberle ◽  
...  

Urology ◽  
2010 ◽  
Vol 76 (5) ◽  
pp. 1224-1230 ◽  
Author(s):  
Mieke J. Aarts ◽  
Floortje Mols ◽  
Melissa S.Y. Thong ◽  
Marieke W. Louwman ◽  
Jan Willem W. Coebergh ◽  
...  

2011 ◽  
Vol 16 (11) ◽  
pp. 1626-1636 ◽  
Author(s):  
Agnès Caravati‐Jouvenceaux ◽  
Guy Launoy ◽  
Delphine Klein ◽  
Michel Henry‐Amar ◽  
Edwige Abeilard ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (11) ◽  
pp. 2754
Author(s):  
Daniela Doege ◽  
Melissa S. Y. Thong ◽  
Linda Weißer ◽  
Lena Koch-Gallenkamp ◽  
Lina Jansen ◽  
...  

(1) Background: Little is known about the health-related quality of life (HRQoL) in very long-term cancer survivors (VLTCS) 10 and more years post-diagnosis. The objective was to compare cancer survivors’ HRQoL 14–24 years post-diagnosis with that of same-aged non-cancer controls, stratified by age, sex, and disease status (disease-free vs. stage IV, recurrence, metastasis, or second cancer). (2) Methods: We recruited 2704 very long-term survivors of breast, colorectal and prostate cancer, and 1765 controls in German multi-regional population-based studies. The HRQoL was assessed by the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). Differences in the HRQoL were estimated with multiple regression, controlling for age, sex (where appropriate), and education. (3) Results: The overall global health status/quality of life of VLTCS more than a decade after diagnosis was slightly higher than that of population controls of the same age, but more symptoms and lower functioning were reported. Differences were small but statistically significant. Results differed by age, sex, and disease status. (4) Conclusions: The findings point out the need for a comprehensive survivorship care program in order to monitor and treat potential late and long-term effects after the diagnosis and treatment of cancer. Survivorship care should be risk-adapted to survivors’ needs according to sociodemographic and clinical factors.


Birth ◽  
2016 ◽  
Vol 44 (2) ◽  
pp. 110-119 ◽  
Author(s):  
Stavros Petrou ◽  
Sung Wook Kim ◽  
Penny McParland ◽  
Elaine M. Boyle

Sign in / Sign up

Export Citation Format

Share Document